+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 18Years +
All Genders
ID07820410

Randomized Study of D-Shant Atrial Shunt Device Plus Guideline-Directed Therapy Versus Medical Therapy Alone for Heart Failure With Reduced Ejection Fraction

Led by Beijing Anzhen Hospital · Updated on 2026-09-15

208

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of an atrial shunt device for treating heart failure with reduced ejection fraction HFrEF. This prospective, randomized, open-label, parallel-controlled multicenter study will involve 208 participants to compare outcomes between those receiving the atrial shunt and those receiving standard medical therapy alone. The study aims to determine whether the atrial shunt can improve heart function and reduce heart failure events. Participants will be randomly assigned to either receive the D-Shant atrial shunt implantation following right heart catheterization or to undergo right heart catheterization alone. Both groups will continue to receive standardized Guideline-Directed Medical Therapy GDMT for heart failure. Follow-up assessments will occur at baseline, the day of procedure, then at 1 week, 1 month, 3 months, 6 months, and 12 months after the procedure. A committee of cardiovascular experts will independently review the primary outcomes without knowing which treatment participants received. During the study, participants will undergo evaluations including heart function tests, echocardiograms, electrocardiograms, and blood tests measuring heart failure markers such as NT-proBNP. Researchers will monitor clinical events like mortality, heart transplants, rehospitalizations for heart failure, and symptom changes over 12 months. Device performance and heart measurements will be tracked in the treatment group. Safety and effectiveness will be assessed through these comprehensive evaluations during the year-long follow-up.

CONDITIONS

Brief Title

Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction

Research Team

S

Sanshuai Chang, M.D.

G

Guangyuan Song, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here